Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.
about
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosisHepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agentsHepcidin levels and their determinants in different types of myelodysplastic syndromes.Second round robin for plasma hepcidin methods: first steps toward harmonization.The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.Serum levels of the hepcidin-20 isoform in a large general population: the Val Borbera study.Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease.Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney diseaseImproved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoformHepcidin and iron disorders: new biology and clinical approaches.Hepcidin and its potential clinical utility.Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA.Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing.Serum hepcidin in inflammatory bowel diseases: biological and clinical significance.Unexplained isolated hyperferritinemia without iron overload.Relationship between hepcidin and ferritin in haemodialysed patients.Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin.A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients?Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
P2860
Q24318821-B0B6DF8C-16FC-4F10-81EA-4B27387BB654Q28727076-74618107-B53A-4E16-8631-4C77118EB5D4Q34008796-2BBE4DB1-9679-42B1-A693-0BE67A623284Q34377416-3E8BC0C9-E0C8-4E05-BD37-8F2377D960EEQ34596298-40FC8346-546C-421F-8FE6-3D676B242E0DQ36431697-E92A6D9C-AEBE-46C5-A879-A7CD2267B4C0Q37118393-3868178E-3443-4B63-9A57-4AC81A512B25Q37195412-DADAB425-6328-4227-8D41-A1E8F0E93079Q37215937-774FF939-35B2-48AD-B5EC-A9B958445F52Q38481982-431DB0CE-E2A9-49EC-8932-0B2A24E7271EQ38537391-FCF93111-0A05-49C8-9B43-EB23ECD4E5C5Q39582910-C1B74C46-516B-4022-AA5F-90F0F6E35097Q42367931-3F17B7D5-C846-4FF1-AEEA-3F8FF0FF7501Q47980971-3D192846-8780-4921-947D-8A5027C14A81Q48096173-D58A3379-1654-430B-97C7-F37B8C58B48AQ50872606-FD9666AC-7F26-4099-A534-ABF59FD3E5B5Q51071449-3FB23AB5-86E8-4B6C-A0A8-F3A734A52F97Q51082188-DF02B2C2-C608-4E7A-8EB3-73CC4D69030CQ51142875-E2695593-81F9-4816-9553-B9C34D3702BF
P2860
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Evaluation of hepcidin isoform ...... pproach based on SELDI-TOF MS.
@ast
Evaluation of hepcidin isoform ...... pproach based on SELDI-TOF MS.
@en
type
label
Evaluation of hepcidin isoform ...... pproach based on SELDI-TOF MS.
@ast
Evaluation of hepcidin isoform ...... pproach based on SELDI-TOF MS.
@en
prefLabel
Evaluation of hepcidin isoform ...... pproach based on SELDI-TOF MS.
@ast
Evaluation of hepcidin isoform ...... pproach based on SELDI-TOF MS.
@en
P2093
P2860
P356
P1476
Evaluation of hepcidin isoform ...... pproach based on SELDI-TOF MS.
@en
P2093
Albino Poli
Annalisa Castagna
Antonio Lupo
Domenico Girelli
Federica Zaninotto
Natascia Campostrini
Nicola Tessitore
Oliviero Olivieri
Valeria Bedogna
P2860
P304
P356
10.1155/2010/329646
P577
2010-04-15T00:00:00Z